EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment for multisystem Langerhans' cell histiocytosis



Treatment for multisystem Langerhans' cell histiocytosis



Journal of Pediatrics 140(2): 280-280




(PDF 0-2 workdays service: $29.90)

Accession: 035980226

Download citation: RISBibTeXText

PMID: 11865293



Related references

Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide. American Journal of Pediatric Hematology/Oncology 16(3): 275-277, 1994

Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X). Medical and Pediatric Oncology 17(2): 97-100, 1989

Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study. International Journal of Hematology 104(1): 99-109, 2016

A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. Journal of Pediatrics 138(5): 728-734, 2001

LCH I A randomized trial of treatment of multisystem Langerhans cell histiocytosis. Pediatric Research 45(4 PART 2): 148A, April, 1999

Denosumab for the treatment of adult multisystem Langerhans cell histiocytosis. Metabolism: Clinical and Experimental 69: 107-111, 2017

Multisystem Langerhans cell histiocytosis: successful treatment with thalidomide. American Journal of Clinical Dermatology 8(5): 311-314, 2007

Marrow transplantation for treatment of multisystem progressive Langerhans cell histiocytosis. Bone Marrow Transplantation 10(1): 39-44, 1992

Immunosuppressive treatment for chemotherapy-resistant multisystem Langerhans cell histiocytosis. Medical and Pediatric Oncology 40(4): 253-256, 2003

Multisystem Langerhans cell histiocytosis in children: current treatment and future directions. Paediatric Drugs 13(2): 75-86, 2011

Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group. Klinische Padiatrie 212(4): 139-144, 2000

Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Medical and Pediatric Oncology 39(6): 581-585, 2002

Treatment of Multifocal Multisystem BRAF Positive Langerhans Cell Histiocytosis with Cladribine, Surgery and Allogenic Stem Cell Transplantation. Acta Medica 60(4): 152-156, 2018

Long-term complete response after treatment with cytarabine, vincristine, and prednisone in an infant with refractory multisystem Langerhans cell histiocytosis. Pediatric Blood & Cancer 57(1): 180-181, 2011

Multisystem Langerhans cell histiocytosis. Acta Paediatrica 88(3): 349-350, 1999